Abstract

Background: The safety of performing elective percutaneous coronary intervention (PCI) in hospitals without surgery on site (SOS) has been questioned. We assessed the safety of this practice in a one year follow up study. Methods: 485 patients underwent elective (PCI) in two network hospitals without (SOS) were followed for one-year in a longitudinal registry. Baseline demographics, hemodynamics, and renal function were recorded for each patient before and after PCI. Clinical data were obtained at 6 weeks, 3, 6, 9, and 12 months. Results: Baseline demographics: Mean age was 68±12 years, 67% were male, BMI: 28.9±5.3. Comorbidities included heart failure-8.4%, carotid artery disease-7%, hypertension-80%, IDDM-9%, NIDDM-20%, PAD-6%, smoking-22%, prior PCI-31%. Systolic BP: 146±24 mmHg, diastolic BP: 79±15 mmHg, creatinine: 1.1±0.7mg/dl, Total Cholesterol: 157±40 mg/dl, EF: 52±14%. Total number of stents used was 558 (28% Bare-metal stents and 72% Drug eluted stents). Death, all cause readmissions, repeat PCI, CABG, and angina symptoms were recorded at each time interval (See table1 ). At one year 95% were taking aspirin and 89% were taking clopidogrel. No correlation was noted between clopidrogel use and repeat PCI. Conclusions: One year follow up after PCI in hospitals without SOS demonstrates acceptable rates of immediate complications and long term outcomes. The data suggest that elective PCI can be performed safely in hospitals without surgery on site. Time Interval Death Readmit Repeat PCI CABG Angina Symptoms 6 weeks 1% 7% 1.2% 1% 6.4% 3 months 0.4% 5% 0.6% 1% 6.9% 6 months 0.8% 7% 1.1% 0% 9.4% 9 months 0.4% 4% 9.3% 1% 10.4% 12 months 0.4% 3% 6.8% 0% 7.4%

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.